683 Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
|
|||||
|
2025
Q1 | – | Hold |
|
|||||
|
2024
Q4 | – | Hold |
|
|||||
|
2024
Q3 | – | Hold |
|
|||||
|
2024
Q2 | – | Hold |
|
|||||
|
2024
Q1 | – | Hold |
|
|||||
|
2023
Q4 | – | Hold |
|
|||||
|
2023
Q3 | – | Hold |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $5.69M | Sell |
|
|||||
|
2022
Q1 | $8M | Hold |
|
|||||
|
2021
Q4 | $8.31M | Hold |
|
|||||
|
2021
Q3 | $9.25M | Sell |
|
|||||
|
2021
Q2 | $9.32M | Hold |
|
|||||
|
2021
Q1 | $7.76M | Sell |
|
|||||
|
2020
Q4 | $13.6M | Hold |
|
|||||
|
2020
Q3 | $15.3M | Hold |
|
|||||
|
2020
Q2 | $15.6M | Sell |
|
|||||
|
2020
Q1 | $18.5M | Sell |
|
|||||
|
2019
Q4 | $25.9M | Sell |
|
|||||
|
2019
Q3 | $28.5M | Buy |
|
|||||
|
2019
Q2 | $24.7M | Buy |
|
|||||
|
2019
Q1 | $30.5M | Hold |
|
|||||
|
2018
Q4 | $23.8M | Buy |
|
|||||
|
2018
Q3 | $26.3M | Hold |
|
|||||
|
2018
Q2 | $29.5M | Buy |
|
|||||
|
2018
Q1 | $22.6M | Sell |
|
|||||
|
2017
Q4 | $25.4M | Sell |
|
|||||
|
2017
Q3 | $28.1M | Sell |
|
|||||
|
2017
Q2 | $21.5M | Hold |
|
|||||
|
2017
Q1 | $13.8M | Hold |
|
|||||
|
2016
Q4 | $10.1M | Buy |
|
|||||
|
2016
Q3 | $8.13M | Buy |
|